5AM Ventures IV, L.P. 4
4 · Homology Medicines, Inc. · Filed Dec 16, 2020
Insider Transaction Report
Form 4
5AM Ventures IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-12-14$13.06/sh−6,297$82,244→ 215,138 total(indirect: See footnote) - Sale
Common Stock
2020-12-14$13.06/sh−151,138$1,973,998→ 5,163,346 total(indirect: See footnote) - Sale
Common Stock
2020-12-14$11.88/sh−13,703$162,792→ 201,435 total(indirect: See footnote) - Sale
Common Stock
2020-12-14$11.88/sh−328,862$3,906,881→ 4,834,484 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares are held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
- [F2]The shares are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.